2003•The Journal of UrologyRequires access

RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence

PAMELA I. ELLSWORTH

Open publisher page 63 citations

Abstract

No AccessJournal of UrologyCLINICAL UROLOGY: Letters to the Editor1 Sep 2003RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence Pamela Ellsworth Pamela EllsworthPamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author View All Author Informationhttps://doi.org/10.1097/01.ju.0000080841.60873.b1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence." The Journal of Urology, 170(3), p. 928 References 1 : Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc1998; 46: 8. Google Scholar 2 : Oxybutynin and cognitive dysfunction. BMJ1997; 315: 1363. Google Scholar 3 : Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol2001; 41: 636. Crossref, Medline, Google Scholar 4 : A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. J Clin Psychiatry1987; 48: 20. Google Scholar 5 : Memory and cognitive function in man: does the cholinergic system have a specific role?. Neurology1977; 27: 783. Google Scholar 6 : Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol1994; 47: 337. Google Scholar Department of Urology, University of Massachusetts Medical School, University Campus, 55 Lake Ave., North, Worcester, Massachusetts 01655© 2003 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 170Issue 3September 2003Page: 928 Advertisement Copyright & Permissions© 2003 by American Urological Association, Inc.MetricsAuthor Information Pamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author Expand All Advertisement PDF downloadLoading ...

About this research paper

What this paper is about

No AccessJournal of UrologyCLINICAL UROLOGY: Letters to the Editor1 Sep 2003RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence Pamela Ellsworth Pamela EllsworthPamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author View All Author Informationhttps://doi.org/10.1097/01.ju.0000080841.60873.b1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence." The Journal of Urology, 170(3), p. 928 References 1 : Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc1998; 46: 8. Google Scholar 2 : Oxybutynin and cognitive dysfunction. BMJ1997; 315: 1363. Google Scholar 3 : Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol2001; 41: 636. Crossref, Medline, Google Scholar 4 : A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. J Clin Psychiatry1987; 48: 20. Google Scholar 5 : Memory and cognitive function in man: does the cholinergic system have a specific role?. Neurology1977; 27: 783. Google Scholar 6 : Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol1994; 47: 337. Google Scholar Department of Urology, University of Massachusetts Medical School, University Campus, 55 Lake Ave., North, Worcester, Massachusetts 01655© 2003 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 170Issue 3September 2003Page: 928 Advertisement Copyright & Permissions© 2003 by American Urological Association, Inc.MetricsAuthor Information Pamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author Expand All Advertisement PDF downloadLoading ...

Why it matters

OpenAlex reports 63 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

No AccessJournal of UrologyCLINICAL UROLOGY: Letters to the Editor1 Sep 2003RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence Pamela Ellsworth Pamela EllsworthPamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author View All Author Informationhttps://doi.org/10.1097/01.ju.0000080841.60873.b1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence." The Journal of Urology, 170(3), p. 928 References 1 : Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc1998; 46: 8. Google Scholar 2 : Oxybutynin and cognitive dysfunction. BMJ1997; 315: 1363. Google Scholar 3 : Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol2001; 41: 636. Crossref, Medline, Google Scholar 4 : A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. J Clin Psychiatry1987; 48: 20. Google Scholar 5 : Memory and cognitive function in man: does the cholinergic system have a specific role?. Neurology1977; 27: 783. Google Scholar 6 : Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol1994; 47: 337. Google Scholar Department of Urology, University of Massachusetts Medical School, University Campus, 55 Lake Ave., North, Worcester, Massachusetts 01655© 2003 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 170Issue 3September 2003Page: 928 Advertisement Copyright & Permissions© 2003 by American Urological Association, Inc.MetricsAuthor Information Pamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author Expand All Advertisement PDF downloadLoading ...

Key concepts: Tolterodine, Oxybutynin, Medicine, Urology, Urinary incontinence, Pharmacology, Overactive bladder, Alternative medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence — Research Paper | ScholarLens